logo
episode-header-image
Sep 2024
10m 22s

ESMO 2024 special: Results of interim an...

EUROPEAN ASSOCIATION OF UROLOGY
About this episode
UROONCO BCa chief editor Dr. Benjamin Pradere talks to Assoc. Prof. Andrea Necchi (IT) at EMSO 2024 on the results of the interim analysis of SunRISe-4 study: TAR-200 plus cetrelimab or CET alone as neoadjuvant therapy in patients with muscle-invasive bladder cancer who are ineligible for or refuse neoadjuvant cisplatin-based chemotherapy. Assoc. Prof. Nec ... Show More
Up next
Mar 17
Special session at EAU26: GU Cast LIVE
Recorded live at EAU26 in London, this special episode features a live recording of GU Cast, bringing a dynamic and interactive format to the congress stage.Hosted by Prof. Declan Murphy (AU) and Prof. Renu Eapen (AU), the session brings together expert guests to discuss updates ... Show More
36m 28s
Mar 15
Special session at EAU26: Challenge the UROmigos
Recorded live at EAU26 in London, this special podcast episode features Prof. Brian Rini (US) and Prof. Tom Powles (GB) hosting an interactive UROmigos discussion with experts from the audience.The session explores evolving treatment strategies and key debates in bladder and kidn ... Show More
49m 32s
Mar 11
ASCO GU26 special: Prof. Karam discusses the results of the LITESPARK-022 study
In this episode, UROONCO RCC chief editor Dr. Carmen Mir talks to Prof. Jose Karam on the results of the LITESPARK-022 study: Adjuvant pembrolizumab plus belzutifan versus pembrolizumab for clear cell renal cell carcinoma (ccRCC): The randomised phase 3 LITESPARK-022 study.The LI ... Show More
12m 5s
Recommended Episodes
Jul 2024
Ep. 178 ASCO 2024: Game-Changing GU Oncology Updates in Bladder and Kidney Cancers with Dr. Sumanta Pal and Dr. Petros Grivas
Stay up-to-date on the latest advancements and treatment strategies in the field of genitourinary oncology. In this episode of BackTable Urology, guest host Dr. Bogdana Schmidt, a urologic oncologist from the University of Utah, discusses takeaways from ASCO 2024 with Dr. Petros ... Show More
57m 23s
Apr 2025
Evolut Low-Risk Trial: 5-year Data Outcomes
Transcatheter aortic valve replacement (TAVR) has emerged as the preferred treatment for aortic stenosis. However, there is a lack of long-term outcome data for low-risk patients. The 5-year results from the Evolut Low-Risk randomized trial address this gap, offering compelling e ... Show More
9m 59s
Dec 2022
PARP Inhibitors in Advanced Prostate Cancer Care
PARP Inhibitors in Advanced Prostate Cancer Care Podcast CME Available: https://auau.auanet.org/node/37321 Host: Jay D. Raman, MD, FACS Guests: Maha Hussain, MD and Ganesh Raj, MD, PhD LEARNING OBJECTIVES At the conclusion of this activity, participants will be able to: 1. Identi ... Show More
40m 20s
Oct 2025
Ep. 267 Sequencing Therapies in NMIBC Management with Dr. Mark Tyson and Dr. Suzanne Merrill
New FDA-approved therapies for BCG-refractory non-muscle invasive bladder cancer (NMIBC)–where do they fit in the treatment algorithm, and how do you administer them? This installment of the 2025 NMIBC Creator Weekend™ series features host Dr. Bogdana Schmidt, assistant professor ... Show More
1 h
Aug 2024
AUA2024:How to use PSMA-PET/CT in the Management of Relapsing Prostate Cancer Patients
How to use Prostate-Specific Membrane Antigen-Positron Emission Tomography/CT in the Management of Relapsing Prostate Cancer Patients following Local Therapy with Curative Intent CME Available: https://auau.auanet.org/node/41124 At the conclusion of this activity, participants wi ... Show More
1h 41m
Jul 2024
Salivary biomarkers: Future clinical and diagnostic applications with Nagihan Bostanci
<p>In the latest episode of the Next Regeneration podcast, hosts Anina and Elena talk to Nagihan Bostanci, the Head of Internationalization in Dentistry and Professor of Inflammation Research in Periodontology at the Karolinska Institute in Stockholm, Sweden. Together they discus ... Show More
32m 9s
Nov 2025
Bispecific Antibodies in Aggressive B-Cell Lymphoma: Real-World Insights and Future Directions
In this week's episode, Blood editor Dr. Laura Michaelis interviews author Dr. Taylor Brooks on his latest paper published in volume 146 issue 18 of Blood Journal. The conversation discusses outcomes of bispecific antibodies (epcoritamab or glofitamab) in treating aggressive B-ce ... Show More
9m 36s
Jul 2025
Journal Review in Minimally Invasive Surgery: Achalasia
Today, we’re diving into a condition that’s as fascinating as it is complex: Achalasia—where the esophagus stops playing nice, and swallowing becomes a daily challenge.We’re breaking down the latest evidence, comparing POEM, pneumatic dilation, and Heller myotomy, and digging int ... Show More
19m 48s
Nov 2024
226. NM Examination Stroke
<p class="MsoNormal" style= "line-height: 150%; mso-pagination: none; tab-stops: 43.05pt; margin: 6.2pt 0in 0in 0in;"> <span style="mso-bidi-font-weight: bold;">A patient with lateral medullary (Wallenburg) syndrome will most likely demonstrate which of the following clinical man ... Show More
10m 16s
Sep 2025
Episode 65. Circulating Tumor DNA in DLBCL with Dr. Ash Alizadeh and Dr. David Russler-Germain
In this episode of Blood Cancer Talks, hosts Eddie, Ashwin, and Raj welcome two distinguished experts to explore the cutting-edge field of circulating tumor DNA (ctDNA) in B-cell lymphomas. Dr. David Russler-Germain, a lymphoma clinician from Siteman Cancer Centre at Washington U ... Show More
53m 8s